Our History
Lupus has been quoted on the London Stock Exchange since 1999. In April 2006, following the acquisition of Schlegel Building Products, the Company transferred its listing from the Official List to the Alternative Investment Market (AIM).
In early 2004 Greg Hutchings made a significant investment in Lupus shares and was appointed as Executive Chairman. Denis Mulhall was appointed as an executive director shortly afterwards and also made a significant investment. Since then, operational management has been reorganised, incentive schemes installed and a mergers and acquisitions function added.
In June 2004 the balance sheet and share premium account of Lupus were restructured by means of a capital reorganisation in order to permit the payment of future dividends.
In March 2006, Lupus announced the acquisition of Schlegel Building Products for £84 million together with a placing and open offer to raise approximately £53 million.
In April 2007, Lupus announced the acquisition of LSSD for £242.5 million, together with a placing and open offer to raise approximately £136 million.
Since the appointment of the current management team in February 2004, the strategy of Lupus has been:
- To build shareholder value through the acquisition of industrial assets with the potential for development
- To apply the executive team’s management skills and systems to improve profitability
- To use a variety of funding mechanics and exit strategies to enhance shareholder value